Sponsor or institution
Clinical trials and research at Idoven 1903 S.L.
As of November 12, 2026, Find a Trial lists 5 clinical trials run by Idoven 1903 S.L. that are recruiting, at sites in 8 countries (most in Spain (4), Germany (2), United States (2)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 8Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Willem AI for early detection of aortic stenosis from a 12‑lead ECG | — | Bonn and 1 other locations | Recruiting | Mar 18, 2026 |
| WILLEM AI ECG registry for adults at high risk of heart disease | — | Nashville, Tennessee and 4 other locations | Recruiting | Jan 12, 2026 |
| AI-powered ECG interpretation to detect heart failure in older primary care patients | — | Madrid and 4 other locations | Recruiting | Aug 8, 2025 |
| AI-powered ECG tool to detect transthyretin cardiac amyloidosis early. | — | Evanston, Illinois and 7 other locations | Recruiting | May 18, 2025 |
| AI analysis of ECGs for high-risk cardiac patients | — | Groningen, Provincie Groningen and 12 other locations | Recruiting | Jun 6, 2023 |
All recruiting trials (5)
-
Willem AI for early detection of aortic stenosis from a 12‑lead ECG
This project will test whether the Willem AI can detect aortic stenosis from routine 12‑lead ECGs in adults.
-
WILLEM AI ECG registry for adults at high risk of heart disease
This registry will test whether the WILLEM AI can read ECGs to detect cardiac abnormalities in adults at high risk for heart disease using real-world hospital and wearable recordings.
-
AI-powered ECG interpretation to detect heart failure in older primary care patients
This trial tests whether the AI tool Willem™ helps primary care doctors detect heart failure from ECGs in people aged 65 and older who have symptoms or are at high cardiovascular risk.
-
AI-powered ECG tool to detect transthyretin cardiac amyloidosis early.
This project will test whether the Willem™ AI ECG platform can tell people with transthyretin cardiac amyloidosis from those without using routine 12‑lead digital ECG recordings.
-
AI analysis of ECGs for high-risk cardiac patients
This study is testing an AI tool that analyzes heart rhythm patterns in high-risk heart patients to see if it can help doctors catch problems earlier and improve patient care.
Quick answers
How many clinical trials run by Idoven 1903 S.L. are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 8 countries. The most sites are in Spain (4 trials), Germany (2 trials), United States (2 trials), Netherlands (1 trial), Sweden (1 trial). Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.